These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27795426)

  • 1. The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells.
    Hutt-Fletcher LM
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.
    Needham J; Adamson AL
    Virus Genes; 2019 Dec; 55(6):779-785. PubMed ID: 31552622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Rta in B Lymphocytes during Epstein-Barr Virus Latency.
    Hwang SP; Huang LC; Wang WH; Lin MH; Kuo CW; Huang HH; Chang LK
    J Mol Biol; 2020 Sep; 432(19):5227-5243. PubMed ID: 32710985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells.
    Reinhart NM; Akinyemi IA; Frey TR; Xu H; Agudelo C; Brathwaite J; Burton EM; Burgula S; McIntosh MT; Bhaduri-McIntosh S
    Virology; 2022 Jan; 566():136-142. PubMed ID: 34922257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ins and outs of EBV infection.
    Faulkner GC; Krajewski AS; Crawford DH
    Trends Microbiol; 2000 Apr; 8(4):185-9. PubMed ID: 10754578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
    Longnecker R
    Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-barr virus gene expression in latent infection and B-lymphocyte growth transformation].
    Harada S
    Uirusu; 2002 Jun; 52(1):129-34. PubMed ID: 12227161
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetic crossroads of the Epstein-Barr virus B-cell relationship.
    Frost TC; Gewurz BE
    Curr Opin Virol; 2018 Oct; 32():15-23. PubMed ID: 30227386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
    Babcock GJ; Hochberg D; Thorley-Lawson AD
    Immunity; 2000 Oct; 13(4):497-506. PubMed ID: 11070168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
    Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
    Front Immunol; 2020; 11():367. PubMed ID: 32194570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.
    Al Tabaa Y; Tuaillon E; Bollore K; Foulongne V; Petitjean G; Seigneurin JM; Duperray C; Desgranges C; Vendrell JP
    Blood; 2009 Jan; 113(3):604-11. PubMed ID: 18845794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    Tatfi M; Hermine O; Suarez F
    Front Immunol; 2018; 9():3060. PubMed ID: 30662441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.
    Shannon-Lowe C; Adland E; Bell AI; Delecluse HJ; Rickinson AB; Rowe M
    J Virol; 2009 Aug; 83(15):7749-60. PubMed ID: 19439479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with Reconstituted Human Immune System Components as a Tool to Study Immune Cell Interactions in EBV Infection.
    Heuts F; Nagy N
    Methods Mol Biol; 2017; 1532():229-240. PubMed ID: 27873280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biological properties of the Epstein-Barr virus LMP1 gene: structure, function and polymorphism].
    Smirnova KV; Diduk SV; Senyuta NB; Gurtsevitch VE
    Vopr Virusol; 2015; 60(3):5-13. PubMed ID: 26281300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.